InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
75%
T+90 mean return
+12.6%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Califf Robert, Director. Insider active across 2 companies, notably Cytokinetics INC. Cumulatively, 10 reports have been published. History available since 12 May 2021. The latest transaction was disclosed on 3 January 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
122 shares@ US$46.000.0001% mcap17.0% of flowCommon StockSEC:0001061983-22-000009:0
122 shares@ US$46.000.0001% mcap34.0% of flowCommon StockSEC:0001061983-22-000009
153 shares@ US$36.740.0001% mcap16.7% of flowCommon StockSEC:0001061983-21-000227:0
153 shares@ US$36.7416.7% of flowCommon StockSEC:0001061983-21-000227
31 shares@ US$19.770.0000% mcap1.8% of flowCommon StockSEC:0001061983-21-000189:0
31 shares@ US$19.771.8% of flowCommon StockSEC:0001061983-21-000189
238 shares@ US$20.9814.5% of flowCommon StockSEC:0001061983-21-000174
238 shares@ US$20.980.0001% mcap14.5% of flowCommon StockSEC:0001061983-21-000174:0
5,000 shares0Common StockSEC:0001061983-21-000137
5,000 shares0Common StockSEC:0001061983-21-000137:0
10 of 10 declarations
About Califf Robert
Robert Califf is a Board Member at Cytokinetics Inc. He is involved in corporate governance and operational oversight. His expertise in the biopharmaceutical sector is an asset for the company's strategic direction.
